2022
DOI: 10.1016/j.envint.2022.107568
|View full text |Cite
|
Sign up to set email alerts
|

Neonicotinoid insecticides promote breast cancer progression via G protein-coupled estrogen receptor: In vivo, in vitro and in silico studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
9
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 60 publications
0
9
0
Order By: Relevance
“…These increase estradiol (E2) synthesis in adrenocortical carcinoma (H295R) and breast cancer (T47D) cells and increase cell proliferation via the estrogen receptors ERα and ERβ. These results indicate that even low concentrations and environmental levels of pesticides cause increased estrogen levels, which, at high levels, are related to potential risk factors for developing, especially, breast cancer in women (58,59,61,66).…”
Section: In Vitro and In Vivo Datamentioning
confidence: 82%
“…These increase estradiol (E2) synthesis in adrenocortical carcinoma (H295R) and breast cancer (T47D) cells and increase cell proliferation via the estrogen receptors ERα and ERβ. These results indicate that even low concentrations and environmental levels of pesticides cause increased estrogen levels, which, at high levels, are related to potential risk factors for developing, especially, breast cancer in women (58,59,61,66).…”
Section: In Vitro and In Vivo Datamentioning
confidence: 82%
“…In particular: Li, He, et al. ( 2022 ). Neonicotinoid insecticides promote breast cancer progression via G protein‐coupled estrogen receptor: In vivo, in vitro and in silico studies.…”
Section: Human Healthmentioning
confidence: 99%
“… In the study of Li, He, et al. ( 2022 ), the effect of acetamiprid on in situ growth of breast cancer cells in female mice and related mechanisms were studied. Ovariectomised and non‐ovariectomised mice were injected with 4T1‐luc cells (murine triple‐negative breast cancer cell line) and exposed daily by oral gavage for 3 weeks to acetamiprid (ovariectomised mice to 0, 1, 10 or 30 mg/kg bw per day; non‐ovariectomised mice to 0 or 10 mg/kg bw per day).…”
Section: Human Healthmentioning
confidence: 99%
See 2 more Smart Citations